Home > Back to Publisher > Report Information

Biocompatible Materials for the Human Body

BCC Research
March 30, 2007
130 Pages - SKU: WA1484494

Abstract Table of Contents Related Reports

This report contains: An examination of the supporting products that have enhanced imaging at the chemical level (reagents and contrast media) and at the analysis level (software tools and image management); The U.S. markets for medical devices, tissue replacements, and surface coating biomaterials for a variety of biomaterials categories including metals, ceramics, polymers, and natural materials; Assessment of the market for specific medical applications including orthopedic surgery, cardiovascular surgery and care, wound management, dentistry, urology, gastrointestinal surgery, ophthalmic care as well as plastics and reconstructive surgery; A review of important technology and a discussion of patents in the past few decades; Profiles of all the major companies in the industry.

INTRODUCTION: STUDY GOAL AND OBJECTIVES; REASONS FOR DOING THE STUDY; INTENDED AUDIENCE; SCOPE OF REPORT; INFORMATION SOURCES; ANALYST’S CREDENTIALS; RELATED BCC REPORTS; BCC ONLINE SERVICES; DISCLAIMER
SUMMARY: SUMMARY TABLE U.S. MARKET FORECAST FOR BIOCOMPATIBLE MATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS); SUMMARY FIGURE U.S. MARKET FOR BIOCOMPATIBLE MATERIALS, BY SEGMENT 2004-2012 ($ MILLIONS)
OVERVIEW: INTRODUCTION TO BIOCOMPATIBLE MATERIALS; TYPES OF MATERIALS; CERAMICS; Ceramics (Continued)
TABLE 1 COMMON BIOCOMPATIBLE CERAMICS: METALS; Titanium; Gold; Platinum
TABLE 2 COMMON BIOCOMPATIBLE METALS: POLYMERS; PLA and PGA; PTFE
TABLE 3 COMMON BIOCOMPATIBLE POLYMERES: Natural Materials; Collagen; Chitosan; Alginate
TABLE 4 COMMON BIOCOMPATIBLE NATURAL MATERIALS: TECHNOLOGY; ADVANCES IN BIOACTIVE MATERIALS; GROWTH FACTORS; DRUG-ELUTING SURFACES; HYDROGELS; Hydrogels for Growth Factor Delivery; Mechanoresponsive Hydrogels; Poly(HEMA); DEGRADABLE OR BIORESORBABLE MATERIALS; Chitosan; Polyethylene Oxide; Ethylene-vinyl Acetate; THE CHALLENGES OF BIOCOMPATIBILITY; BLOOD COMPATIBILITY AND PROTEIN ADSORPTION; Albumin; Immunoglobulins; Fibrinogen; CALCIFICATION; INFECTION AND BIOFILMS; HOST IMMUNE RESPONSE; Wound Healing and Inflammation; Foreign Body Immune Reaction and Rejection; Complement Immune Response; RECENT ADVANCES IN ENABLING TECHNOLOGIES; BIOMIMETICS; NANOTECHNOLOGY; TISSUE ENGINEERING; STEM CELLS; BIOREACTOR TECHNOLOGY; PATENT ANALYSIS; PATENTS BY TECHNOLOGY
TABLE 5 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY TECHNOLOGY, JANUARY 2006-JANUARY 2007
FIGURE 1 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY TECHNOLOGY, JANUARY 2006-JANUARY 2007 (%): PATENTS BY MEDICAL APPLICATION
TABLE 6 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY MEDICAL APPLICATION, JANUARY 2006-JANUARY 2007
FIGURE 2 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY MEDICAL APPLICATION, JANUARY 2006-JANUARY 2007 (%): PATENTS BY REGION/OR COUNTRY (DEPENDING ON DISTRIBUTION)
TABLE 7 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY REGION, JANUARY 2006-JANUARY 2007
FIGURE 3 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY COUNTRY, JANUARY 2006-JANUARY 2007 (%): PATENTS BY ASSIGNEE
TABLE 8 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY ASSIGNEE AFFILIATION, JANUARY 2006-JANUARY 2007
FIGURE 4 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY ASSIGNEE AFFILIATION, JANUARY 2006-JANUARY 2007 (%)
TABLE 9 BIOCOMPATIBLE MATERIALS ISSUED PATENTS BY ASSIGNEE, JANUARY 2006-JANUARY 2007
TABLE 9 (CONTINUED)
TABLE 9 (CONTINUED)
TABLE 9 (CONTINUED)
TABLE 9 (CONTINUED): PATENTS OF INTEREST; Patent Title: Triggered Release Hydrogel Drug Delivery; System; Patent Title: Adaptive Memory Prioritization for Implanted Medical Devices; Patent Title: Coumarin Endcapped Absorbable Polymers; Bioabsorbable Polymeric Implants and a Method Of Using The Same to Create Occlusions; SPECIAL ISSUES IN CARDIAC STENT PATENTING; Special Issues in Cardiac …(Continued); GOVERNMENT REGULATION; FDA REGULATION OF MEDICAL DEVICES; BIOMATERIALS ACCESS ASSURANCE ACT OF 1998; REGULATION OF TISSUE ENGINEERED PRODUCTS; FDA REGULATION OF GOOD TISSUE PRACTICES; GOVERNMENT REGULATION OF NANOMATERIALS; NEW FDA APPROVALS; Novel Hernia Repair Material; Low Pressure Perfusion Catheter; Real-Time Continuous Glucose Monitor; Omega-3 Fatty Acid Coated Mesh; Wireless Telemetry and Cardiac Rhythm Management; Implants; Wireless Telemetry … (Continued); MARKET FOR BIOCOMPATIBLE MATERIALS
TABLE 10 U.S. MARKET FORECAST FOR BIOCOMPATIBLE MATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS): IMPLANTABLE MEDICAL DEVICES
TABLE 11 U.S. MARKET FORECAST FOR IMPLANTABLE MEDICAL DEVICES BY SEGMENT, THROUGH 2012 ($ MILLIONS)
FIGURE 5 U.S. MARKET FOR IMPLANTABLE MEDICAL DEVICES, BY SEGMENT 2004-2012 ($ MILLIONS): TISSUE REPLACEMENTS
TABLE 12 U.S. MARKET FORECAST FOR TISSUE REPLACEMENTS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 12 (CONTINUED)
FIGURE 6 U.S. MARKET FOR TISSUE REPLACEMENTS, BY SEGMENT 2004-2012 ($ MILLIONS): SURFACE COATINGS
TABLE 13 U.S. MARKET FORECAST FOR BIOCOMPATIBLE SURFACE COATINGS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
FIGURE 7 U.S. MARKET FOR BIOCOMPATIBLE SURFACE COATINGS BY SEGMENT, 2004-2012 ($ MILLIONS): SURFACE COATINGS (CONTINUED); U.S. MARKET FOR BIOMATERIALS, BY APPLICATION
TABLE 14 U.S. MARKET FORECAST FOR BIOMATERIALS BY APPLICATION, THROUGH 2012 ($ MILLIONS)
FIGURE 8 U.S. MARKET FOR BIOMATERIALS, BY MEDICAL APPLICATION 2004-2012 ($ MILLIONS): ORTHOPEDIC APPLICATIONS
TABLE 15 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS, BY SEGMENT THROUGH 2012 ($ MILLIONS)
FIGURE 9 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS, BY SEGMENT, 2004-2012 ($ MILLIONS): BONE-PLATE MATERIALS; Bone-Plate Materials (Continued); HIP REPLACEMENTS; Hip Resurfacing; KNEE REPLACEMENTS; Non-constrained Implants; Semi-constrained Implants; Constraint or Hinged Implants; Unicondylar Knee Replacement; SPINAL IMPLANTS; Types of Spinal Implants; Disc Arthroplasty; THE MARKET FOR ORTHOPEDIC BIOMATERIALS; CARDIOVASCULAR APPLICATIONS
TABLE 16 U.S. MARKET FORECAST FOR CARDIOVASCULAR BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS): CARDIAC PACEMAKERS; IMPLANTABLE CARDIOVERTER DEFIBRILLATORS; ImplanTABLE Cardioverter … (Continued); CARDIAC STENTS; Metal Stents; Drug-Eluting Stents (DES); Rapamycin and Related Immunosuppressants; Paclitaxel; Drug-Eluting Stents And Complications; HEART VALVES; Percutaneous Implant; VASCULAR ACCESS DEVICES; Midline Catheter; Peripherally Inserted Central Catheter (PICC); Tunneled Catheter; Subcutaneous Port; PERIPHERAL VASCULAR GRAFTS
FIGURE 10 U.S. MARKET FOR CARDIOVASCULAR BIOMATERIALS, BY SEGMENT 2004-2012 ($ MILLIONS): WOUND MANAGEMENT APPLICATIONS
TABLE 17 U.S. MARKET FORECAST FOR WOUND MANAGEMENT BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
FIGURE 11 U.S. MARKET FOR WOUND MANAGEMENT BIOMATERIALS BY SEGMENT, 2004-2012 ($ MILLIONS): TISSUE SEALANTS AND HEMOSTATS; Bovine Serum/Albumin/Glutaraldehyde; Fibrin; Gelatin Matrix/Thrombin Sealants; Polyethylene Glycol Hydrogels; ADHESION BARRIERS
TABLE 18 TYPES OF ADHESION BARRIERS AND MANUFACTURERS: SKIN SUBSTITUTES; Skin Substitutes (Continued)
TABLE 19 MAJOR SKIN SUBSTITUTE PRODUCTS: Skin Substitutes (Continued); Genetically Modified Skin Cells; GASTROINTESTINAL APPLICATIONS
TABLE 20 U.S. MARKET FORECAST FOR GASTROINTESTINAL BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
FIGURE 12 U.S. MARKET FOR GASTROINTESTINAL BIOMATERIALS, BY SEGMENT, 2004-2012 ($ MILLIONS): UROLOGICAL BIOMATERIALS
TABLE 21 U.S. MARKET FORECAST FOR UROLOGY BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS): URETERAL STENTS; URETHRAL STENTS; URINARY CATHETERS; Removal; Resistance to Encrustation; Biofilms
FIGURE 13 U.S. MARKET FOR UROLOGY BIOMATERIALS BY SEGMENT, 2004-2012 ($ MILLIONS): THE MARKET FOR UROLOGY BIOMATERIALS; PLASTIC SURGERY
TABLE 22 U.S. MARKET FORECAST FOR PLASTIC SURGERY BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS): BREAST IMPLANTS; Saline-Filled Implants; Silicone Gel Implants; Safety Considerations; Breakage and Leakage; Breakage and Leakage (Continued); Scarring; Platinum; INJECTABLE FILLERS; Zyderm and Zyplast Collagen; Fibrel; Artecoll; Hylan B Gel; Resoplast; Autologen; Isolagen; Dermalogen; AlloDerm; Fat Injections
TABLE 23 COLLAGEN FILLERS: FACIAL IMPLANTS; Teflon; Polyethylene; Hydroxyapatite
FIGURE 14 U.S. MARKET FOR PLASTIC SURGERY BIOMATERIALS, BY SEGMENT 2004-2012 ($ MILLIONS): THE MARKET FOR PLASTIC SURGERY BIOMATERIALS; The Market for Plastic … (Continued); ON THE HORIZON; BIOMATERIALS FOR GENE AND PROTEIN DELIVERY; ELECTROSPINNING SCAFFOLDS; COMPANY PROFILES; ABIOMED, INC; ADVANCED BIONICS CORPORATION; ALLERGAN INC; BAXTER INTERNATONAL INC; BIOINTERACTIONS LTD.; BIOMET, INC; COCHLEAR CORPORATION; CONMED CORPORATION; DEPUY ORTHOPAEDICS, INC.; ENCORE ORTHOPEDICS; GUIDANT CORP.; INTERPORE CROSS INTERNATIONAL; JOHNSON & JOHNSON MEDICAL, INC; MEDICAL ELECTRONICS (MED-EL); MEDTRONIC, INC.; MENTOR CORPORATION; MIV THERAPEUTICS; SOFAMOR DANEK GROUP; STAAR SURGICAL COMPANY; STRYKER CORPORATION; SULZER MEDICA; SULZER MEDICA (CONTINUED); SYNTHES CORPORATION; THORATEC LABORATORIES; ZIMMER CORP; MARKET SHARE; MARKET SHARE OF MAJOR COMPANIES’ IMPLANTABLE MEDICAL DEVICES
TABLE 24 MARKET SHARE OF MAJOR COMPANIES’ IMPLANTABLE MEDICAL DEVICES (%)
FIGURE 15 MARKET SHARE OF MAJOR COMPANIES IN IMPLANTABLE MEDICAL DEVICES (%): MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS BIOMATERIALS
TABLE 25 MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS (%)
FIGURE 16 MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS (%): MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS
TABLE 26 MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS (%)
FIGURE 17 MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS (%)
LIST OF TABLES: SUMMARY TABLE U.S. MARKET FORECAST FOR BIOCOMPATIBLE MATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 1 COMMON BIOCOMPATIBLE CERAMICS
TABLE 2 COMMON BIOCOMPATIBLE METALS
TABLE 3 COMMON BIOCOMPATIBLE POLYMERES
TABLE 4 COMMON BIOCOMPATIBLE NATURAL MATERIALS
TABLE 5 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY TECHNOLOGY, JANUARY 2006-JANUARY 2007
TABLE 6 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY MEDICAL APPLICATION, JANUARY 2006-JANUARY 2007
TABLE 7 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY REGION, JANUARY 2006-JANUARY 2007
TABLE 8 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY ASSIGNEE AFFILIATION, JANUARY 2006-JANUARY 2007
TABLE 9 BIOCOMPATIBLE MATERIALS ISSUED PATENTS BY ASSIGNEE, JANUARY 2006-JANUARY 2007
TABLE 10 U.S. MARKET FORECAST FOR BIOCOMPATIBLE MATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 11 U.S. MARKET FORECAST FOR IMPLANTABLE MEDICAL DEVICES BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 12 U.S. MARKET FORECAST FOR TISSUE REPLACEMENTS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 13 U.S. MARKET FORECAST FOR BIOCOMPATIBLE SURFACE COATINGS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 14 U.S. MARKET FORECAST FOR BIOMATERIALS BY APPLICATION, THROUGH 2012 ($ MILLIONS)
TABLE 15 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS, BY SEGMENT THROUGH 2012 ($ MILLIONS)
TABLE 16 U.S. MARKET FORECAST FOR CARDIOVASCULAR BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 17 U.S. MARKET FORECAST FOR WOUND MANAGEMENT BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 18 TYPES OF ADHESION BARRIERS AND MANUFACTURERS
TABLE 19 MAJOR SKIN SUBSTITUTE PRODUCTS
TABLE 20 U.S. MARKET FORECAST FOR GASTROINTESTINAL BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 21 U.S. MARKET FORECAST FOR UROLOGY BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 22 U.S. MARKET FORECAST FOR PLASTIC SURGERY BIOMATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
TABLE 23 COLLAGEN FILLERS
TABLE 24 MARKET SHARE OF MAJOR COMPANIES’ IMPLANTABLE MEDICAL DEVICES (%)
TABLE 25 MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS (%)
TABLE 26 MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS (%)
LIST OF FIGURES: SUMMARY FIGURE U.S. MARKET FOR BIOCOMPATIBLE MATERIALS, BY SEGMENT 2004-2012 ($ MILLIONS)
FIGURE 1 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY TECHNOLOGY, JANUARY 2006-JANUARY 2007 (%)
FIGURE 2 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY MEDICAL APPLICATION, JANUARY 2006-JANUARY 2007 (%)
FIGURE 3 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY COUNTRY, JANUARY 2006-JANUARY 2007 (%)
FIGURE 4 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY ASSIGNEE AFFILIATION, JANUARY 2006-JANUARY 2007 (%)
FIGURE 5 U.S. MARKET FOR IMPLANTABLE MEDICAL DEVICES, BY SEGMENT 2004-2012 ($ MILLIONS)
FIGURE 6 U.S. MARKET FOR TISSUE REPLACEMENTS, BY SEGMENT 2004-2012 ($ MILLIONS)
FIGURE 7 U.S. MARKET FOR BIOCOMPATIBLE SURFACE COATINGS BY SEGMENT, 2004-2012 ($ MILLIONS)
FIGURE 8 U.S. MARKET FOR BIOMATERIALS, BY MEDICAL APPLICATION 2004-2012 ($ MILLIONS)
FIGURE 9 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS, BY SEGMENT, 2004-2012 ($ MILLIONS)
FIGURE 10 U.S. MARKET FOR CARDIOVASCULAR BIOMATERIALS, BY SEGMENT 2004-2012 ($ MILLIONS)
FIGURE 11 U.S. MARKET FOR WOUND MANAGEMENT BIOMATERIALS BY SEGMENT, 2004-2012 ($ MILLIONS)
FIGURE 12 U.S. MARKET FOR GASTROINTESTINAL BIOMATERIALS, BY SEGMENT, 2004-2012 ($ MILLIONS)
FIGURE 13 U.S. MARKET FOR UROLOGY BIOMATERIALS BY SEGMENT, 2004-2012 ($ MILLIONS)
FIGURE 14 U.S. MARKET FOR PLASTIC SURGERY BIOMATERIALS, BY SEGMENT 2004-2012 ($ MILLIONS)
FIGURE 15 MARKET SHARE OF MAJOR COMPANIES IN IMPLANTABLE MEDICAL DEVICES (%)
FIGURE 16 MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS (%)
FIGURE 17 MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS (%)

Biocompatible Materials for the Human Body

Share this report

Other tasks

Research Assistance

Related Markets

Nanomedicine Reports

Free Alert Me service